Skip to main content
    Q

    Quest Diagnostics Incorporated (DGX)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $256.36
    -5.85 (-2.23%)

    Market Cap: $28.85B

    Last updated: Nov 17, 2026 at 4:24 PM ET

    Quest Diagnostics Incorporated (DGX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Quest Diagnostics (DGX) has a market cap of $28.85B and an enterprise value of $33.60B. Its trailing P/E of 23.2x is above its 10-year median of 16.5x.

    Total Valuation

    Enterprise value is 16.48% above the market cap, as debt exceeds cash.

    Market Cap$28.85B
    Enterprise Value$33.60B
    Latest price (Nov 17, 2026)$256.36

    Key Dates

    The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Jan 12, 2027.

    Next Earnings DateFeb 8, 2027 (expected)
    Last Earnings DateOct 22, 2026
    Next Ex-Dividend DateJan 12, 2027
    Next Payment DateJan 27, 2027
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.90% in the quarter ended Sep 30, 2026 and shrank 0.90% a year over 2 years.

    Shares Outstanding110.00M
    Shares Change (YoY)-1.79%
    Shares Change (QoQ)-0.90%
    Share Count Growth (2Y CAGR)-0.90%

    Valuation Ratios

    Sales and book value multiples are 2.4x and 3.7x. Its year-end P/E ranged from 10.7x to 17.9x from 2016 to 2025.

    P/E Ratio23.2x
    Forward P/E22.4x
    P/S Ratio2.4x
    Forward P/S2.4x
    P/B Ratio3.7x
    P/FCF Ratio20.5x
    P/OCF Ratio14.8x
    PEG Ratio2.7

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 14.2x EBITDA and 24.0x free cash flow.

    EV / Earnings28.5x
    EV / Sales2.8x
    EV / EBITDA14.2x
    EV / EBIT19.3x
    EV / FCF24.0x

    Price Statistics

    The stock is up 38.33% over 52 weeks and trades 5.99% above its 50-day average.

    Beta (1Y)-0.06
    52-Week Change+38.33%
    1-Month Change+9.13%
    3-Month Change+6.44%
    6-Month Change+35.72%
    5-Year Change+71.56%
    10-Year Change+209.21%
    Total Return (1Y)+40.16%
    Total Return (3Y CAGR)+25.53%
    Total Return (5Y CAGR)+13.45%
    Return vs SPY (1Y)+27.99%
    Max Drawdown (1Y)-11.89%
    Max Drawdown (3Y)-12.44%
    Sharpe Ratio (1Y)1.41
    Correlation with SPY (1Y)-0.03
    50-Day Average$241.88
    200-Day Average$215.45
    52-Week Range$168.34 to $263.19
    RSI (14 Days)59.9
    Average Volume (20 Days)953.33K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.70x current liabilities, and total debt is 0.73x shareholder equity.

    Current Ratio1.70x
    Quick Ratio1.58x
    Debt / Equity0.73x
    Debt / EBITDA2.38x
    Debt / FCF4.04x

    Returns and Efficiency

    Return on invested capital is 10.19% over the last 12 months, against a 5-year average of 11.56%.

    Return on Equity (ROE)15.46%
    Return on Assets (ROA)6.85%
    Return on Invested Capital (ROIC)10.19%
    Return on Capital Employed (ROCE)11.33%
    ROE (5Y Average)18.42%
    ROA (5Y Average)8.36%
    ROIC (5Y Average)11.56%
    Asset Turnover0.71x
    Inventory Turnover35.12x
    Receivables Turnover7.01x
    Cash Conversion Cycle-12 days

    Taxes

    Income tax took 22.92% of pretax income over the last 12 months.

    Income Tax (TTM)$342.00M
    Effective Tax Rate22.92%

    Scores

    DGX has an Altman Z-Score of 3.81, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score3.81
    Altman Z ZoneSafe
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $11.84B over the last 12 months is up 9.13% from the 12 months before.

    Revenue$11.84B
    Revenue Growth (YoY)+9.13%
    Gross Profit$3.92B
    Operating Income$1.72B
    Pretax Income$1.49B
    Net Income$1.18B
    EBITDA$2.33B
    EBIT$1.74B
    Reported EPS (TTM)$11.04

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 44.31% of the $17.22B in total assets.

    Cash and Equivalents$797.00M
    Total Debt$5.55B
    Net Debt$4.75B
    Net Debt Per Share$43.21
    Working Capital$1.28B
    Shareholder Equity$7.63B
    Book Value Per Share$69.38
    Tangible Book Value-$3.11B
    Total Assets$17.22B
    Total Liabilities$9.19B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $576.00M of capital spending, operating cash flow left $1.38B of free cash flow.

    Operating Cash Flow$1.95B
    Capital Expenditures$576.00M
    Free Cash Flow$1.38B
    FCF Per Share$12.46
    Depreciation and Amortization$585.00M
    Dividends Paid$417.00M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 14.55%, against a 5-year average of 15.58%.

    Gross Margin33.11%
    Operating Margin14.55%
    Pretax Margin12.60%
    Net Margin9.97%
    EBITDA Margin19.66%
    EBIT Margin14.72%
    FCF Margin11.61%
    Gross Margin (5Y Average)34.56%
    Operating Margin (5Y Average)15.58%
    Net Margin (5Y Average)11.63%

    Growth

    Revenue grew 3.74% a year over 3 years, and EPS fell 0.24% a year.

    Revenue Growth (3Y CAGR)+3.74%
    Revenue Growth (5Y CAGR)+3.18%
    EPS Growth (3Y CAGR)-0.24%
    EPS Growth (5Y CAGR)-2.45%
    FCF Growth (3Y CAGR)+1.13%
    FCF Growth (5Y CAGR)-3.05%
    Operating Income Growth (3Y CAGR)+2.90%
    Book Value Per Share Growth (2Y CAGR)+7.10%

    Revenue and profit by year

    Dividends and Yields

    DGX pays out 19.06% of earnings as dividends.

    Dividend Per Share (Annual)$3.44
    Dividend Yield1.34%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+6.61%
    Dividend Growth (5Y CAGR)+7.35%
    Payout Ratio19.06%
    FCF Payout Ratio30.33%
    Earnings Yield4.31%
    FCF Yield4.88%
    Buyback Yield1.60%
    Shareholder Yield3.07%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on Jun 21, 2005.

    Last Split DateJun 21, 2005
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 11 similar companies, DGX has the 8th highest P/E and the 5th highest ROIC.

    P/E Ratio23.2x vs 28.4x median
    P/S Ratio2.4x vs 6.0x median
    ROIC10.19% vs 8.20% median
    Revenue Growth (Trailing 4 Quarters, YoY)+9.13% vs +6.27% median
    Dividend Yield1.34% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 6.95% and EPS growth at 10.30% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+6.95%
    EPS Growth Forecast (2Y CAGR)+10.30%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DGX

    What is DGX's market cap?

    Quest Diagnostics has a market cap of $28.85B. Its enterprise value, which adds debt and subtracts cash, is $33.60B.

    What is DGX's P/E ratio?

    Quest Diagnostics has a trailing P/E ratio of 23.2x and a forward P/E of 22.4x.

    How many shares of DGX are outstanding?

    Quest Diagnostics has 110.00M shares outstanding. The count is down 1.79% from a year earlier.

    Does DGX pay a dividend?

    Yes. Quest Diagnostics pays $3.44 a share a year, a dividend yield of 1.34%.

    How much debt does DGX have?

    Quest Diagnostics has $5.55B of total debt and $797.00M of cash and equivalents, a net debt position of $4.75B.